Search





Search





Markets
/
Stocks
/
nasdaq-vrxa
/

Veraxa Biotech AG Ord Shs

VRXA

Add to Watchlist

2.419USD

+0.119+5.16%

Market hours （ET）Quotes delayed by 15 min

76.49MMarket Cap

--P/E TTM

Veraxa Biotech AG Ord Shs

2.419

+0.119+5.16%

Earnings Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Earnings Income Statement Balance Sheet Cash Flow Statement

You can access the annual and quarterly cash flow statements of Veraxa Biotech AG Ord Shs to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---149.31K

Net income from continuing operations

--180.50K

Change in working capital

--2.04M

-Change in payables and accrued expense

--1.98M

-Change in other current liabilities

--62.60K

Cash from non-recurring investing activities

Cash from operating activities

---149.31K

Investing cash flow

Cash from non-current investing activities

Financing cash flow

Net cash from non-recurrent financing activities

Net cash flow

Beginning cash balance

--182.10K

Current period cash flow changes

---149.31K

Ending cash balance

--32.79K

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

